about
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquineStrong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trialA Partial Convergence in Action of Methylene Blue and Artemisinins: Antagonism with Chloroquine, a Reversal with Verapamil, and an Insight into the Antimalarial Activity of ChloroquineInteractions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparumSafety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug targetMethylene blue reduced abnormal tau accumulation in P301L tau transgenic miceNeuroprotective actions of methylene blue and its derivativesGlutathione reductase-null malaria parasites have normal blood stage growth but arrest during development in the mosquitoPhenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps.The phenothiazinium chromophore and the evolution of antimalarial drugs.Resistance of human butyrylcholinesterase to methylene blue-catalyzed photoinactivation; mass spectrometry analysis of oxidation products.Plasmodium drug targets outside the genetic control of the parasite.Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice.Methylene blue: revisited.Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene bluePotent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.Pharmacogenomic strategies against resistance development in microbial infections.Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stressThe Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling.Antifungal Action of Methylene Blue Involves Mitochondrial Dysfunction and Disruption of Redox and Membrane Homeostasis in C. albicans.1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agentsRole of Mitochondria in Neonatal Hypoxic-Ischemic Brain InjuryDisease animal models of TDP-43 proteinopathy and their pre-clinical applications.Cytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis.Antimicrobial dyes and mechanosensitive channels.Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.Characterization of swim bladder non-inflation (SBN) in angelfish, Pterophyllum scalare (Schultz), and the effect of exposure to methylene blue.Diagnosis of red cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping.In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisininsAntiplasmodial activities of dyes against Plasmodium falciparum asexual and sexual stages: Contrasted uptakes of triarylmethanes Brilliant green, Green S (E142), and Patent Blue V (E131) by erythrocytes.Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation?Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs.PharmGKB summary: methylene blue pathway.Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
P2860
Q21033481-32A9C6E0-7467-4D3B-BEEF-6EB31C25C9ECQ21562479-6DB6133C-F994-4236-A050-E0903CB6AA72Q22061977-6C30E221-F885-4E9E-9D2F-DC52AF477FF2Q24657634-A587EF1F-0303-464F-A046-8BC5C1EE647EQ24815501-B3BAF9F9-D71E-4C3A-B9B2-FA79A03B5614Q27974089-97FE4599-B5B5-4D30-9768-88A418BA8EF3Q28484481-F9B32629-C0C9-4F21-A6DF-BD82D86FEC47Q28484659-9670BD59-AC5D-4CE8-B901-2AFD5E7C0E27Q34094450-D6B30077-6C49-4931-9822-B697148A367BQ34301578-36E8C34B-2ECF-415D-A3FF-0B21C46DD3A7Q34424514-41ECC686-C929-4E00-BAE0-9C6FDA8DC532Q34471002-9C723577-470A-44A0-BEB7-FBE15315DF03Q34678568-BED33A64-4597-4CDA-8FF2-900E41F819B3Q34710568-D8152557-B406-423E-B0E7-E0DBD134DD40Q34920262-3C0518D5-B58B-4E06-B8EA-05463F8A7D65Q34921079-AB27F301-96B3-4AF2-8A38-234B3A3B8CC0Q35571456-62EE33A7-5E9B-4FEC-BA96-38051387840BQ35701564-4A6FCCC4-5390-43FD-BCFC-747CC21A2736Q35785222-68E73B41-2956-444B-8B65-CBC1D7B9D4ECQ35858632-E4EA8191-DC19-4E43-8E69-DAC65E9F3C5AQ36051237-89A8B2AE-9F2C-4AF2-B8DA-622EE148383BQ36124336-CBA436DE-7B3A-49FA-81D4-5CFDE319DCD6Q36450015-F08BA340-25A0-41A8-B10D-AC1BDCEA36F2Q36658607-3925A7D7-A560-40B0-8149-C38F15D7F0C9Q36914067-3AF7FF32-38F4-4B2B-9832-83E7FAAFFF53Q37103110-A114D099-E71B-4D2E-82EE-182D6937BB4CQ37291234-DB590FCE-0C13-4EEF-A8C3-82C09CE33637Q37418342-97D11A21-9BFD-4DB9-848C-8028D728A7B5Q38112572-D900DF71-2FBD-4017-AC40-54DDDA66AD8CQ38245842-7269F815-A537-4F45-B445-E49D3E22CE5BQ38438843-A0234ED1-7443-4368-8F81-25896643C1E3Q39242193-C9CB6E6D-8AB4-421F-957E-AB0503FFF428Q39610759-DF49D952-01BC-4CD0-8D66-1A85A23BCEE7Q40050625-728C5E8B-CC43-4290-BEBA-7EE3BDDA2B04Q40069067-6E9FF59F-12C0-43CA-A9B0-325BD6BB7F56Q40600918-BEEAE6F3-887A-4C9C-ACE5-550CE5108D28Q41119883-86BCBFDE-8F83-4B5E-A2C4-04CF28EF2702Q41890556-64A4C18F-F2CE-4A43-96C2-BFC98BFDEAB5Q41912859-29081D26-CACC-4F60-BFE0-F78E52C532DCQ41927945-723006CE-5D77-407C-9637-84DF3BC8A8E0
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Methylene blue as an antimalarial agent.
@ast
Methylene blue as an antimalarial agent.
@en
Methylene blue as an antimalarial agent.
@nl
type
label
Methylene blue as an antimalarial agent.
@ast
Methylene blue as an antimalarial agent.
@en
Methylene blue as an antimalarial agent.
@nl
prefLabel
Methylene blue as an antimalarial agent.
@ast
Methylene blue as an antimalarial agent.
@en
Methylene blue as an antimalarial agent.
@nl
P2093
P2860
P1433
P1476
Methylene blue as an antimalarial agent.
@en
P2093
August Stich
Bocar Kouyaté
Boubacar Coulibaly
Heiko Merkle
Jana Eubel
Michael Scheiwein
Olaf Müller
R Heiner Schirmer
Thomas Zich
Wolfgang Schiek
P2860
P304
P356
10.1179/135100003225002899
P577
2003-01-01T00:00:00Z